Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
I. Mahmutovic Persson (Lund, Sweden). Preclinical models and imaging biomarkers of lung injury and disease. Virtual Congress 2021 – Emerging imaging biomarkers in lung disease

Member's Comments

No comment yet.

Related content which might interest you: Novel imaging biomarkers for assessment of lung fibrosis and inflammation Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Longitudinal micro-CT of preclinical models of lung disease provides biomarkers of disease and therapy that reveal compensatory changes in lung volume Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases. Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Molecular imaging of the progression of pulmonary fibrosis using animal models of disease Source: Eur Respir J 2006; 28: Suppl. 50, 605s Year: 2006 Progress in modelling acute lung injury in a pre-clinical mouse model Source: Eur Respir J 2012; 39: 1062-1063 Year: 2012 3he MRI and an animal model of interstitial lung disease Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 Emerging diagnostics from MRI, PET and CT studies of lung disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD) Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease Year: 2020 Longitudinal micro-CT-derived biomarkers: the new standard readouts for preclinical evaluation of pulmonary fibrosis and therapy Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 FDG-microPET imaging to comfirm brain death in a mouse model: A useful tool to study related donor lung injury Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model Source: Eur Respir J 2006; 28: Suppl. 50, 606s Year: 2006 Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Murine models of cardiovascular damage in lung diseases Source: Eur Respir Monogr 2020; 88: 31-46 Year: 2020 Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening Source: Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020 Year: 2021 Pre-clinical models of COPD and its comorbidities Source: Annual Congress 2009 - COPD comorbidities: translational approaches Year: 2009 Multimodal imaging approaches in suspected and confirmed lung cancer Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018 Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation Source: Eur Respir J 2013; 42: 1633-1645 Year: 2013 Longitudinal imaging characterisation of a model of chronic allergic lung inflammation in mice Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Optimising disease models for lung diseases and drug development Source: International Congress 2015 – Development and application of new approaches for respiratory disease research Year: 2015